These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8175959)

  • 1. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.
    Holte J; Bergh T; Berne C; Berglund L; Lithell H
    J Clin Endocrinol Metab; 1994 May; 78(5):1052-8. PubMed ID: 8175959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
    Holte J; Bergh T; Berne C; Wide L; Lithell H
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2586-93. PubMed ID: 7673399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?
    Gennarelli G; Holte J; Wide L; Berne C; Lithell H
    Hum Reprod; 1998 Mar; 13(3):535-41. PubMed ID: 9572406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome.
    Holte J
    Baillieres Clin Endocrinol Metab; 1996 Apr; 10(2):221-47. PubMed ID: 8773746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A; Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
    Barber TM; Casanueva FF; Karpe F; Lage M; Franks S; McCarthy MI; Wass JA
    Eur J Endocrinol; 2008 Apr; 158(4):511-6. PubMed ID: 18362298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
    Falcone T; Finegood DT; Fantus IG; Morris D
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1653-7. PubMed ID: 2146285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action.
    Aroda V; Ciaraldi TP; Chang SA; Dahan MH; Chang RJ; Henry RR
    Fertil Steril; 2008 May; 89(5):1200-1208. PubMed ID: 17706206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism.
    Luque-Ramírez M; Alpañés M; Escobar-Morreale HF
    Fertil Steril; 2010 Nov; 94(6):2214-21. PubMed ID: 20097337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.